FDA approves FUROSCIX® for use in pediatric patients weighing 43kg or aboveUSPTO issues five patents for FUROSCIX ReadyFlow™ AutoinjectorWESTLAKE ...

The authors provide a useful integrated analytical approach to investigating MASLD focused on diverse multiomic integration methods. The strength of evidence for this new resource is solid, as ...

Telehealth Platform Offers Compounded GLP-1 Injections and Oral Tablets at $299/Month With No Contract as 100,000+ Patients Seek Affordable Semaglutide Access Heading Into New Year Weight Loss Season ...

If approved, ReadyFlow Autoinjector would deliver an IV-equivalent diuretic dose (subcutaneous furosemide injection 80 mg/ml) in under 10 seconds Would potentially provide a cost-effective and ...

This is where things get really forward-thinking. Medtronic GPT is starting to use predictive analytics to spot diseases even ...

Smart cities use IoT to manage traffic better and use resources like water and energy more wisely. The energy sector is using IoT to manage power grids and integrate renewable sources more effectively ...

The U.K. MHRA’s newly released framework offers long-awaited clarity by outlining when digital mental health technologies ...

MIT develops needle-free glucose monitor using light technology. Revolutionary device could replace painful finger pricks for ...

Patients are being warned to stop using some glucose monitors made by Abbott Diabetes Care after the company found malfunctioning sensors may be linked to hundreds of adverse events and several deaths ...

Nasha is a Managing Editor for CNET, overseeing our sleep and wellness verticals. She is a nutrition, mental health, fitness and sleep science enthusiast. Her passion for mindful and holistic ...

Health Canada is asking diabetes patients to check if their glucose monitor is subject to an international recall that has serious health risks. The federal agency is recalling some FreeStyle Libre 3 ...

“Patients should verify if their sensors are impacted and immediately discontinue use and dispose of the affected sensor (s),” the FDA said. “If undetected, incorrect low glucose readings over an ...